Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure.
about
Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury.Mechanisms of beta-receptor stimulation-induced improvement of acute lung injury and pulmonary edemaBench-to-bedside review: beta2-Agonists and the acute respiratory distress syndromeContribution of α - and β -Adrenergic Mechanisms to the Development of Pulmonary EdemaDenopamine stimulates alveolar fluid clearance via cystic fibrosis transmembrane conductance regulator in rat lungsβ2-Adrenergics in hypoxia desensitize receptors but blunt inhibition of reabsorption in rat lungsRandomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cellsPreventing ARDS: progress, promise, and pitfallsInhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury.Salt-inducible kinase 1 is present in lung alveolar epithelial cells and regulates active sodium transportAdvancing donor management research: design and implementation of a large, randomized, placebo-controlled trial.Proteomics: current techniques and potential applications to lung disease.Alveolar epithelial beta 2-adrenergic receptors: their role in regulation of alveolar active sodium transport.Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury.Integrated control of lung fluid balance.Clinical review: Early treatment of acute lung injury--paradigm shift toward prevention and treatment prior to respiratory failureEffects of salbutamol on exhaled breath condensate biomarkers in acute lung injury: prospective analysisAlveolar epithelial beta2-adrenergic receptors.The rise and fall of β-agonists in the treatment of ARDS.Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine.Increased cardiac index due to terbutaline treatment aggravates capillary-alveolar macromolecular leakage in oleic acid lung injury in dogsA randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors.The clinical practice guideline for the management of ARDS in Japan.Inhalation therapies in acute respiratory distress syndrome.Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung.Selected contribution: long-term effects of beta(2)-adrenergic receptor stimulation on alveolar fluid clearance in mice.PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization.The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.Beta-adrenergic agonist therapy as a potential treatment for acute lung injury.Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality.Chronic β2AR stimulation limits CFTR activation in human airway epithelia.
P2860
Q24800694-1F6B8EFB-A0D1-4B6B-9147-89542066ECB1Q24800734-60DC0023-1670-4F7B-9AB6-6A3C8C92CCBFQ24806211-A29F3646-ED63-4B53-8E9B-3DA40B12D6D1Q26853675-B6EE8E7C-C062-42A3-A78B-659632A64FA2Q28568536-75BDF5D5-AFD5-4A6F-BD3D-4F53ED5AD661Q28568840-4D21EEA1-B0FF-4348-B183-84E8C73A47F3Q30425088-01B46B26-D360-4463-B956-CBB931D8B8F0Q33578314-9A1EFF39-31D4-4838-838D-FF238A0D8428Q34299807-59799AC3-6EB8-47DE-A47A-D901A2B96138Q34999196-5060228C-F261-4ABA-8B74-79F09B88E79EQ35020405-E1D0138F-263A-4098-B11B-FF0D4C78D487Q35574081-E974B651-DC52-413C-8905-B1274463487EQ35798681-B9038565-8972-4FB5-B8D5-411D67422C44Q35901530-CDDB9604-F608-4F09-9C1C-ADA2E9012CB5Q35913061-D74257EA-B95C-4D81-95DC-3451DA5790E0Q35942414-59E4072E-65DF-43FE-BBBF-15AF26A64BA2Q36633471-745B6D98-AC2F-41CD-ABAE-C0AD9BD4B5D5Q36787248-72304928-EDFD-41E9-B76D-D65145713B7CQ36914692-57DAE8E5-AE33-4820-A1AE-18F248A43D8CQ36925720-B9BC3B61-CE68-464A-A100-DE7CD62E1CFDQ37394870-89CD7CB0-67DA-4794-BFA0-C31F3662C753Q37443184-5309D144-0545-443D-A8E2-E3C3E98BD511Q37702895-C196B47F-7C2D-44BF-96D9-E74C9D640D12Q41117178-E3538278-FD3F-431D-A8EE-F1C6EA156B9EQ41190745-B5712623-8DC4-4F8F-ACE3-7E7CA964AC09Q44180865-35C729DD-DCBD-4DB4-BDDE-3D35E080D1A1Q44180868-0E983134-AE1A-4B75-AA58-124AD7AD2C87Q46453474-99E555BA-7038-4753-8815-5684E25730A9Q46778273-9A44EF29-4ED0-448F-8F8D-59F852688461Q47649796-D36389DD-5677-418D-B67B-A0D9D8149541Q47874594-AE3825AE-58DF-41EC-AE78-6E6A7910151AQ51749305-E4BB8A68-0591-4895-9B1F-F30E20C2639A
P2860
Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Aerosolized beta(2)-adrenergic ...... ith acute respiratory failure.
@ast
Aerosolized beta(2)-adrenergic ...... ith acute respiratory failure.
@en
type
label
Aerosolized beta(2)-adrenergic ...... ith acute respiratory failure.
@ast
Aerosolized beta(2)-adrenergic ...... ith acute respiratory failure.
@en
prefLabel
Aerosolized beta(2)-adrenergic ...... ith acute respiratory failure.
@ast
Aerosolized beta(2)-adrenergic ...... ith acute respiratory failure.
@en
P2093
P1476
Aerosolized beta(2)-adrenergic ...... ith acute respiratory failure.
@en
P2093
Brian Daniel
Kamran Atabai
Mary E Snider
Patrick Koch
Thomas J Nuckton
P2888
P304
P356
10.1007/S00134-002-1282-X
P577
2002-05-17T00:00:00Z